Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
University of Miami
Thomas Jefferson University
Thomas Jefferson University
Affimed GmbH
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
Thomas Jefferson University
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
University of Cologne
Baylor College of Medicine
University of Nebraska
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
University of Birmingham
St. Jude Children's Research Hospital
Eastern Cooperative Oncology Group
Northside Hospital, Inc.
Fred Hutchinson Cancer Center
Thomas Jefferson University
University of Liege
National Institutes of Health Clinical Center (CC)
University of Alabama at Birmingham
The Lymphoma Academic Research Organisation
Alliance for Clinical Trials in Oncology
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
St. Jude Children's Research Hospital
Martin-Luther-Universität Halle-Wittenberg
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
King Abdullah International Medical Research Center
University of Maryland, Baltimore
Fred Hutchinson Cancer Center
National Heart, Lung, and Blood Institute (NHLBI)
University of Cologne
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Montefiore Medical Center
Stanford University